Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS

PaperCitations, authors & open-access status

Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 556 citations, 2020 year and bronze oa status.

556
Citations
2020
Year
bronze
OA Status

Related on ScholarIQ

François Salachas
Author
New England Journal of Medicine
Journal
Amyotrophic Lateral Sclerosis Research
Topic
Amyotrophic Lateral Sclerosis Research
Topic
Genetic Neurodegenerative Diseases
Topic
Tuberous Sclerosis Complex Research
Topic
470M+ articles · free account